We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Optima Coronary Artery Disease (CAD) (Optimal Mechanical Evaluation)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00896142
First Posted: May 11, 2009
Last Update Posted: November 22, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Pittsburgh
  Purpose
To evaluate the impact of left ventricular (LV) lead location on LV mechanical function.

Condition
Heart Failure Ischemic Cardiomyopathy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Optima CAD (Optimal Mechanical Evaluation)

Further study details as provided by University of Pittsburgh:

Enrollment: 50
Study Start Date: October 2006
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
18+ years of age must be patients of UPMC Cardiovascular Institute
Criteria

Inclusion Criteria

  1. Ischemic Cardiomyopathy
  2. Left ventricular ejection fraction less than 40%
  3. Clinical indication for invasive electrophysiology testing
  4. Patient is at least 18 years of age

Exclusion Criteria

  1. Unstable angina, acute myocardial infarction and/or revascularization procedure within 3 months
  2. CVA or TIA within the past 6 months
  3. Prosthetic heart valve
  4. Patient is status post heart transplant
  5. Women who are pregnant or with child -bearing potential and who are not on a reliable form of birth control. Women of child-bearing potential are routinely tested for pregnancy as part of the standard of care prior to EPS procedures being performed.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00896142


Locations
United States, Pennsylvania
UPMC Presybterian
Pittsburgh, Pennsylvania, United States, 15213
Sponsors and Collaborators
University of Pittsburgh
Investigators
Principal Investigator: David S. Schwartzman, MD University of Pittsburgh
  More Information

Responsible Party: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00896142     History of Changes
Other Study ID Numbers: 0601112
First Submitted: May 8, 2009
First Posted: May 11, 2009
Last Update Posted: November 22, 2011
Last Verified: November 2011

Keywords provided by University of Pittsburgh:
ischemic cardiomyopathy
cardiac resynchronization therapy
LV structure and function

Additional relevant MeSH terms:
Heart Failure
Cardiomyopathies
Heart Diseases
Cardiovascular Diseases